David A. Siegel Nkarta, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Nkarta, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 103,500 shares of NKTX stock, worth $212,174. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,500Holding current value
$212,174% of portfolio
0.0%Shares
11 transactions
Others Institutions Holding NKTX
# of Institutions
120Shares Held
61.3MCall Options Held
17.6KPut Options Held
1.11M-
Ra Capital Management, L.P. Boston, MA10.8MShares$22.2 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$8.32 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$7.72 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$7.32 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$7.31 Million0.0% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $99.7M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...